Price to Book Value (P/BV)
since 2005
Calculation
Vertex Pharmaceuticals Inc., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Shareholders’ equity1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | 7.24 | = | 462.58 | ÷ | 63.90 | 63.90 | = | 16,409,600 | ÷ | 256,789,869 | |
| Feb 15, 2024 | 6.26 | = | 426.29 | ÷ | 68.06 | 68.06 | = | 17,580,400 | ÷ | 258,307,816 | |
| Feb 10, 2023 | 5.50 | = | 297.40 | ÷ | 54.12 | 54.12 | = | 13,912,700 | ÷ | 257,091,441 | |
| Feb 9, 2022 | 6.16 | = | 244.24 | ÷ | 39.67 | 39.67 | = | 10,100,000 | ÷ | 254,576,691 | |
| Feb 11, 2021 | 6.30 | = | 210.50 | ÷ | 33.42 | 33.42 | = | 8,686,815 | ÷ | 259,960,062 | |
| Feb 13, 2020 | 10.23 | = | 240.09 | ÷ | 23.47 | 23.47 | = | 6,085,244 | ÷ | 259,268,593 | |
| Feb 13, 2019 | 10.68 | = | 185.25 | ÷ | 17.35 | 17.35 | = | 4,435,203 | ÷ | 255,656,889 | |
| Feb 15, 2018 | 20.14 | = | 160.94 | ÷ | 7.99 | 7.99 | = | 2,028,579 | ÷ | 253,891,984 | |
| Feb 23, 2017 | 18.42 | = | 85.73 | ÷ | 4.66 | 4.66 | = | 1,156,582 | ÷ | 248,438,127 | |
| Feb 16, 2016 | 22.38 | = | 85.37 | ÷ | 3.81 | 3.81 | = | 939,967 | ÷ | 246,391,955 | |
| Feb 13, 2015 | 25.60 | = | 113.66 | ÷ | 4.44 | 4.44 | = | 1,075,006 | ÷ | 242,088,884 | |
| Feb 11, 2014 | 14.77 | = | 84.98 | ÷ | 5.75 | 5.75 | = | 1,356,405 | ÷ | 235,771,942 | |
| Mar 1, 2013 | 10.08 | = | 46.17 | ÷ | 4.58 | 4.58 | = | 999,180 | ÷ | 218,188,628 | |
| Feb 22, 2012 | 10.05 | = | 37.60 | ÷ | 3.74 | 3.74 | = | 786,843 | ÷ | 210,335,993 | |
| Feb 17, 2011 | 16.16 | = | 39.85 | ÷ | 2.47 | 2.47 | = | 503,973 | ÷ | 204,412,712 | |
| Feb 19, 2010 | 7.45 | = | 40.70 | ÷ | 5.47 | 5.47 | = | 1,096,346 | ÷ | 200,576,408 | |
| Feb 17, 2009 | 21.09 | = | 33.10 | ÷ | 1.57 | 1.57 | = | 238,874 | ÷ | 152,189,782 | |
| Feb 11, 2008 | 8.92 | = | 18.21 | ÷ | 2.04 | 2.04 | = | 271,295 | ÷ | 132,964,533 | |
| Mar 1, 2007 | 7.52 | = | 30.03 | ÷ | 3.99 | 3.99 | = | 505,935 | ÷ | 126,650,456 | |
| Mar 16, 2006 | 18.12 | = | 39.49 | ÷ | 2.18 | 2.18 | = | 239,176 | ÷ | 109,734,852 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Vertex Pharmaceuticals Inc. Annual Report.
Comparison to Competitors
Vertex Pharmaceuticals Inc., P/BV, long-term trends, comparison to competitors
| Vertex Pharmaceuticals Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | 7.24 | 102.40 | 26.61 | 6.98 | 3.00 | 57.93 | 7.36 | 5.30 | 4.99 | 1.68 | 2.67 | 4.09 |
| Feb 15, 2024 | 6.26 | 29.97 | 24.94 | 3.35 | 3.47 | 65.80 | 4.01 | 5.48 | 8.68 | 1.75 | 3.96 | 4.57 |
| Feb 10, 2023 | 5.50 | 15.52 | 35.01 | 4.88 | 3.64 | 29.36 | 4.90 | 5.37 | 6.07 | 2.48 | 3.77 | 4.83 |
| Feb 9, 2022 | 6.16 | 16.53 | 18.51 | 4.07 | 4.16 | 25.28 | 3.65 | 5.90 | 5.05 | 3.35 | 3.60 | 5.18 |
| Feb 11, 2021 | 6.30 | 14.18 | 14.53 | 3.55 | 3.93 | 35.07 | 4.33 | 6.72 | 7.46 | 2.98 | 4.81 | 5.15 |
| Feb 13, 2020 | 10.23 | — | 13.84 | 2.80 | 3.72 | 51.67 | 3.93 | 6.61 | 7.83 | 3.00 | 3.79 | 4.16 |
| Feb 13, 2019 | 10.68 | — | 9.41 | 5.89 | 2.80 | 12.87 | 3.89 | 6.08 | 7.79 | 3.80 | 5.07 | 3.75 |
| Feb 15, 2018 | 20.14 | 36.95 | 5.02 | 8.88 | 2.58 | 7.33 | 5.15 | 5.79 | 4.30 | 2.94 | 5.66 | 3.30 |
| Feb 23, 2017 | 18.42 | 21.24 | 4.14 | 5.66 | 2.56 | 6.33 | 4.88 | 4.72 | 4.51 | 3.40 | 8.58 | 2.86 |
| Feb 16, 2016 | 22.38 | 22.17 | 3.94 | 7.04 | 2.53 | 5.51 | 6.59 | 4.07 | 3.15 | 2.84 | 10.53 | 2.42 |
| Feb 13, 2015 | 25.60 | 56.09 | 4.59 | 6.72 | 2.63 | 5.14 | 10.08 | 4.01 | 3.42 | 2.95 | 16.22 | 2.51 |
| Feb 11, 2014 | 14.77 | 18.05 | 4.30 | 5.92 | 2.38 | 3.69 | 11.36 | 3.50 | 3.35 | 2.69 | 16.74 | 2.90 |
| Mar 1, 2013 | 10.08 | 18.06 | 3.57 | 4.40 | 2.23 | 4.15 | 7.01 | 3.29 | 2.44 | 2.42 | 12.91 | 1.72 |
| Feb 22, 2012 | 10.05 | — | 2.83 | 3.50 | 2.17 | 3.35 | 5.08 | 3.13 | 2.14 | 1.95 | 19.19 | 1.38 |
| Feb 17, 2011 | 16.16 | — | 2.04 | 2.76 | 2.39 | 3.21 | 5.29 | 2.88 | 1.85 | 1.75 | 6.42 | 1.41 |
| Feb 19, 2010 | 7.45 | — | 2.46 | 2.88 | 2.07 | 4.17 | 6.74 | 3.45 | 1.97 | 1.57 | 5.49 | 1.29 |
| Feb 17, 2009 | 21.09 | — | 2.48 | 3.29 | 1.69 | 5.01 | 9.83 | 3.56 | 2.72 | 1.44 | 2.94 | 1.02 |
| Feb 11, 2008 | 8.92 | — | 2.77 | 4.22 | 2.62 | 4.16 | 11.76 | 4.17 | 5.38 | 2.32 | 3.24 | 1.62 |
| Mar 1, 2007 | 7.52 | — | 3.96 | 5.50 | 3.32 | 5.43 | 18.07 | 4.78 | 5.45 | 2.49 | 5.77 | 1.38 |
| Mar 16, 2006 | 18.12 | — | 4.26 | 4.00 | 3.78 | 5.85 | 9.18 | 4.66 | 4.30 | 2.94 | 8.16 | 2.03 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Vertex Pharmaceuticals Inc., P/BV, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Vertex Pharmaceuticals Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 13, 2025 | 7.24 | 7.03 |
| Feb 15, 2024 | 6.26 | 6.77 |
| Feb 10, 2023 | 5.50 | 5.66 |
| Feb 9, 2022 | 6.16 | 5.72 |
| Feb 11, 2021 | 6.30 | 5.99 |
| Feb 13, 2020 | 10.23 | 5.82 |
| Feb 13, 2019 | 10.68 | 6.02 |
| Feb 15, 2018 | 20.14 | 5.14 |
| Feb 23, 2017 | 18.42 | 4.58 |
| Feb 16, 2016 | 22.38 | 4.15 |
| Feb 13, 2015 | 25.60 | 4.47 |
| Feb 11, 2014 | 14.77 | 3.97 |
| Mar 1, 2013 | 10.08 | 3.21 |
| Feb 22, 2012 | 10.05 | 2.55 |
| Feb 17, 2011 | 16.16 | 2.25 |
| Feb 19, 2010 | 7.45 | 2.37 |
| Feb 17, 2009 | 21.09 | 2.60 |
| Feb 11, 2008 | 8.92 | 3.42 |
| Mar 1, 2007 | 7.52 | 3.82 |
| Mar 16, 2006 | 18.12 | 4.00 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Vertex Pharmaceuticals Inc., P/BV, long-term trends, comparison to industry (health care)
| Vertex Pharmaceuticals Inc. | Health Care | |
|---|---|---|
| Feb 13, 2025 | 7.24 | 5.29 |
| Feb 15, 2024 | 6.26 | 5.25 |
| Feb 10, 2023 | 5.50 | 73,885.60 |
| Feb 9, 2022 | 6.16 | 4.84 |
| Feb 11, 2021 | 6.30 | 4.63 |
| Feb 13, 2020 | 10.23 | 4.47 |
| Feb 13, 2019 | 10.68 | 4.48 |
| Feb 15, 2018 | 20.14 | 4.32 |
| Feb 23, 2017 | 18.42 | 3.88 |
| Feb 16, 2016 | 22.38 | 3.53 |
| Feb 13, 2015 | 25.60 | 3.98 |
| Feb 11, 2014 | 14.77 | 3.37 |
| Mar 1, 2013 | 10.08 | 2.74 |
| Feb 22, 2012 | 10.05 | 2.40 |
| Feb 17, 2011 | 16.16 | 2.14 |
| Feb 19, 2010 | 7.45 | 2.26 |
| Feb 17, 2009 | 21.09 | 2.45 |
| Feb 11, 2008 | 8.92 | 3.27 |
| Mar 1, 2007 | 7.52 | 3.76 |
| Mar 16, 2006 | 18.12 | 3.91 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).